Table 1 |
||||||||||
|
RNAi with C. elegans ubiquitin-conjugating enzyme genes |
||||||||||
| Cosmid |
Gene name |
dsRNA source |
Fragment size (bp) |
Chromosome |
Number of RNAi trials |
Embryonic lethality % |
Secondary phenotype |
Embryonic lethality (%) brood A |
Embryonic lethality (%)brood B |
Secondary phenotype |
|
|
||||||||||
| Feeding method |
Injection method |
|||||||||
|
|
|
|||||||||
| UBC proteins |
||||||||||
| B0403.2 |
ubc-17 |
gen PCR |
591 |
X |
2 |
3.4 |
Normal |
- |
- |
- |
| C06E2.3 |
ubc-21 |
gen PCR |
1131 |
X |
2 |
0 |
Normal |
- |
- |
- |
| C06E2.7 |
ubc-22 |
gen PCR |
1075 |
X |
2 |
0 |
Normal |
- |
- |
- |
| C28G1.1 |
ubc-23 |
gen PCR |
491 |
X |
2 |
0 |
Normal |
- |
- |
- |
| C35B1.1 |
ubc-1 |
pR1.7 |
593 |
IV |
2 |
0 |
Normal |
0 |
0 |
Normal |
| D1022.1 |
ubc-6 |
yk640 h7 |
750 |
II |
2 |
6.9 |
Normal |
- |
- |
- |
| F29B9.6 |
ubc-9 |
yk312e11 |
1160 |
IV |
4 |
60.2 |
Evl, abnormal morphology |
2.7 |
18.2 |
Evl, Egl, abnormal morphology |
| F40G9.3 |
ubc-20 |
yk246g3 |
835 |
III |
4 |
0 |
Rare arrest at L3 stage |
4.8 |
0 |
Some arrest at L3 to L4 stage* |
| F49E12.4 |
ubc-24 |
gen PCR |
842 |
II |
2 |
0 |
Normal |
- |
- |
- |
| F58A4.10 |
ubc-7 |
yk486g12 |
500 |
III |
2 |
0 |
Normal |
- |
- |
- |
| M7.1 |
let-70 |
cDNA |
444 |
IV |
- |
- |
- |
- |
51 |
L3 stage arrest |
| (ubc-2) |
||||||||||
| R01H2.6 |
ubc-18 |
yk461f2 |
584 |
III |
2 |
0 |
Normal |
- |
- |
- |
| R09B3.4 |
ubc-12 |
yk486f10 |
630 |
I |
6 |
85.3 |
Evl, abnormal morphology |
5.8 |
52.3 |
Evl, abnormal morphology |
| Y110A2AR.2 |
ubc-15 |
yk602e10 |
644 |
II |
2 |
0 |
Normal |
- |
- |
- |
| Y54E5B.4 |
ubc-16 |
yk137b4 |
679 |
I |
2 |
0 |
Normal |
1.0 |
1.4 |
Normal |
| Y54G2A.23 |
ubc-13 |
yk659d2 |
499 |
IV |
2 |
0 |
Normal |
- |
- |
- |
| Y69H2.6 |
ubc-19 |
yk290g1 |
635 |
V |
2 |
0 |
Normal |
0.8 |
1.1 |
Normal |
| Y71G12B.15 |
ubc-3 |
yk255b2 |
1053 |
I |
2 |
0 |
Normal |
1.6 |
2.0 |
Normal |
| Y87G2A.9 |
ubc-14 |
yk573c8 |
532 |
I |
6 |
54.1 |
Abnormal morphology |
- |
- |
- |
| Y94H6A.6 |
ubc-8 |
gen PCR |
890 |
IV |
2 |
0 |
Normal |
- |
- |
- |
| UEV proteins |
||||||||||
| F39B2.2 |
uev-1 |
yk593d12 |
499 |
I |
2 |
0 |
Normal |
- |
- |
- |
| F56D2.4 |
uev-2 |
gen PCR |
1074 |
III |
2 |
0 |
Normal |
- |
- |
- |
| F26H9.7 |
uev-3 |
RT-PCR |
660 |
I |
2 |
0 |
Normal |
- |
-- |
|
|
|
||||||||||
|
Gene names have been assigned as indicated in the text. DNA fragments of the indicated sizes were obtained from the cDNA sources shown or from fragments obtained by genomic PCR (gen PCR), or by reverse transcription from RNA (RT-PCR). Phenotypes include Evl (everted vulva) and Egl (egg-laying defect). Embryonic lethality for broods A and B are shown separately. A dash indicates experiment not done. *Variable penetrance. Two potential C. elegansubc genes that have recently come to light are not included in this table. F25H2.8 encodes a protein that is 25% identical to UBC-1 over 100 amino acids spanning the active site. This UBC domain is not recognized by Pfam, but is recognized by SMART (UBCc domain). The protein is 56% identical in amino-acid sequence to Drosophila BG:25E8.2 and therefore belongs in group I of Figures 1 and 2. RNAi experiments with F25H2.8 produce paralysis in the adult stage and premature death of the hermaphrodites 4 to 5 days after the beginning of oviposition [85]. YAC clone Y110A2AM may contain another ubc gene (currently uncurated) encoding a protein 52% identical over 143 amino acids to Y110A2AR.2 (group XVIII). |
||||||||||
|
Jones et al. Genome Biology 2001 3:research0002.1 doi:10.1186/gb-2001-3-1-research0002 |
||||||||||